| Dr George L Mckay, MD | |
|
7400 Lynn Ave, Hamlin, WV 25523-1138 | |
| (304) 824-5806 | |
| (304) 824-5885 |
| Full Name | Dr George L Mckay |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 32 Years |
| Location | 7400 Lynn Ave, Hamlin, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205800869 | NPI | - | NPPES |
| 110117516 | Other | WV | RR MC |
| 5925144 | Other | WV | AETNA |
| 6535584 | Other | WV | SIGNA |
| 1803377000 | Medicaid | WV | |
| 001719144 | Other | WV | MS BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 17476 (West Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lincoln County Primary Care Center Inc | 6204821879 | 22 |
News Archive
As of Dec. 1, fewer than 4,500 people had signed up for coverage through the state's online insurance marketplace, leading to apologies from its new director and talk of postponing the deadline for enrollment for January coverage.
A whole-genome scan to identify large-scale chromosomal damage can help doctors choose the best treatment option for children with neuroblastoma, one of the most common types of childhood cancer, finds an international collaboration jointly led by The Institute of Cancer Research, London.
Concert Pharmaceuticals, Inc. today announced that it has initiated a Phase 1 clinical trial with CTP-354. CTP-354 is a novel GABAA receptor subtype-selective modulator that has demonstrated no sedation at therapeutic doses in preclinical models in contrast to existing GABAA receptor non-selective agonists, such as benzodiazepines.
Consumption of ultra-processed foods has increased over the past two decades across nearly all segments of the U.S. population, according to a new study by researchers at NYU School of Global Public Health.
Cardiac Network, Inc. (PINKSHEETS: CNWI) reported today that it is continuing the expansion of its technology development initiatives for its products and services in anticipation of servicing its agreement with American Wholesale Health, or AWH, that was announced on June 22, 2009.
› Verified 2 days ago
| Entity Name | Lincoln County Primary Care Center Inc |
|---|---|
| Entity Type | Part B Supplier - Public Health/welfare Agency |
| Entity Identifiers | NPI Number: 1942274543 PECOS PAC ID: 6204821879 Enrollment ID: O20040415000138 |
News Archive
As of Dec. 1, fewer than 4,500 people had signed up for coverage through the state's online insurance marketplace, leading to apologies from its new director and talk of postponing the deadline for enrollment for January coverage.
A whole-genome scan to identify large-scale chromosomal damage can help doctors choose the best treatment option for children with neuroblastoma, one of the most common types of childhood cancer, finds an international collaboration jointly led by The Institute of Cancer Research, London.
Concert Pharmaceuticals, Inc. today announced that it has initiated a Phase 1 clinical trial with CTP-354. CTP-354 is a novel GABAA receptor subtype-selective modulator that has demonstrated no sedation at therapeutic doses in preclinical models in contrast to existing GABAA receptor non-selective agonists, such as benzodiazepines.
Consumption of ultra-processed foods has increased over the past two decades across nearly all segments of the U.S. population, according to a new study by researchers at NYU School of Global Public Health.
Cardiac Network, Inc. (PINKSHEETS: CNWI) reported today that it is continuing the expansion of its technology development initiatives for its products and services in anticipation of servicing its agreement with American Wholesale Health, or AWH, that was announced on June 22, 2009.
› Verified 2 days ago
| Entity Name | Lincoln County Primary Care Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457610594 PECOS PAC ID: 6204821879 Enrollment ID: O20121005000142 |
News Archive
As of Dec. 1, fewer than 4,500 people had signed up for coverage through the state's online insurance marketplace, leading to apologies from its new director and talk of postponing the deadline for enrollment for January coverage.
A whole-genome scan to identify large-scale chromosomal damage can help doctors choose the best treatment option for children with neuroblastoma, one of the most common types of childhood cancer, finds an international collaboration jointly led by The Institute of Cancer Research, London.
Concert Pharmaceuticals, Inc. today announced that it has initiated a Phase 1 clinical trial with CTP-354. CTP-354 is a novel GABAA receptor subtype-selective modulator that has demonstrated no sedation at therapeutic doses in preclinical models in contrast to existing GABAA receptor non-selective agonists, such as benzodiazepines.
Consumption of ultra-processed foods has increased over the past two decades across nearly all segments of the U.S. population, according to a new study by researchers at NYU School of Global Public Health.
Cardiac Network, Inc. (PINKSHEETS: CNWI) reported today that it is continuing the expansion of its technology development initiatives for its products and services in anticipation of servicing its agreement with American Wholesale Health, or AWH, that was announced on June 22, 2009.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr George L Mckay, MD 7400 Lynn Ave, Hamlin, WV 25523-1138 Ph: (304) 824-5806 | Dr George L Mckay, MD 7400 Lynn Ave, Hamlin, WV 25523-1138 Ph: (304) 824-5806 |
News Archive
As of Dec. 1, fewer than 4,500 people had signed up for coverage through the state's online insurance marketplace, leading to apologies from its new director and talk of postponing the deadline for enrollment for January coverage.
A whole-genome scan to identify large-scale chromosomal damage can help doctors choose the best treatment option for children with neuroblastoma, one of the most common types of childhood cancer, finds an international collaboration jointly led by The Institute of Cancer Research, London.
Concert Pharmaceuticals, Inc. today announced that it has initiated a Phase 1 clinical trial with CTP-354. CTP-354 is a novel GABAA receptor subtype-selective modulator that has demonstrated no sedation at therapeutic doses in preclinical models in contrast to existing GABAA receptor non-selective agonists, such as benzodiazepines.
Consumption of ultra-processed foods has increased over the past two decades across nearly all segments of the U.S. population, according to a new study by researchers at NYU School of Global Public Health.
Cardiac Network, Inc. (PINKSHEETS: CNWI) reported today that it is continuing the expansion of its technology development initiatives for its products and services in anticipation of servicing its agreement with American Wholesale Health, or AWH, that was announced on June 22, 2009.
› Verified 2 days ago
Dr. Kerri Greer Donahue, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7400 Lynn Ave, Hamlin, WV 25523 Phone: 304-824-5806 Fax: 304-824-5804 |